Recall StatusTerminated
Date Initiated2021-12-01
Date Terminated2023-07-07
Product QuantityUS: 46 units OUS: 794 units
Reason for Recall
2 Microglobulin (B2M) Reagent Lot 211446 Bias with Quality Control and Patient Sample Results. Positive bias on patient samples of up to +20.9% at a B2M concentration of approximately 1.5 mg/L and a negative bias on patient samples of up to -10.5% at a B2M concentration of approximately 15 mg/L
Firm Action
Siemens issued An Urgent Medical Device Correction (UMDC) letter to US customers by FedEx beginning on 2021-12-01. An Urgent Field Safety Notice (UFSN) was issued to all OUS Siemens sites with affected customers electronically for distribution and regional reporting to their local competent authorities beginning on 2021-12-01.
Letter states reason for recall, health risk and action to take:
Discontinue use of and discard the kit lot listed in Table 1.
Review your inventory of this product to determine your laboratory s replacement needs and
to provide information to Siemens Healthineers for reporting to the authorities.
Please review this letter with your Medical Director.
Complete and return the Field Correction Effectiveness Check Form attached to this letter
within 30 days.
If you have received any complaints of illness or adverse events associated with the
product listed in Table 1, immediately contact your local Siemens Healthineers Customer
Care Center or your local Siemens Healthineers technical support representative.
Please retain this letter with your laboratory records and forward this letter to those who may have received this product.
If you have any questions, contact your Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative.
Root Cause
Under Investigation by firm
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of CA, CO, MA, MD, MS, NC, NE, NH, OH, VA, WI and the countries of Argentina, Australia, Austria, Belgium,
Brazil, Bulgaria, Czech Republic, Denmark, Ecuador, France, Germany, Greece, India, Iran, Israel, Italy, Japan, Mexico, Morocco, Oman, P.R. China, Pakistan, Philippines, Portugal, Slovakia, South Africa, Spain, Switzerland, Turkey, United Kingdom, Uruguay.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.